Depending on your health history, goals, side effects, and weight maintenance needs, your provider may discuss options such as a slower dose reduction, a lower maintenance dose, or another long-term treatment strategy
Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option
It is not a substitute for professional advice or help and should not be relied on to make decisions of any kind
A PA denial on the drug pulls down the administration code with it in most payer systems
One in 6 (17%) of those with a semaglutide/tirzepatide-type prescription also had history of a mental health condition other than alcohol use disorder versus 9% in those without a prescription
Most healthcare providers recommend that semaglutide users consume at least 1,200 to 1,500 calories daily for women and 1,500 to 1,800 for men, even when appetite is minimal